Skip to content
10-K

Annual Report

SUPERNUS PHARMACEUTICALS, INC. SUPN

0001356576-26-000011

← back to feed
Filed
Mar 2, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 24, 2026 57.58M sh
Shares Diluted FY 2025 · Dec 31, 2025 56.45M sh
Shares Diluted FY 2025 · Dec 31, 2024 55.96M sh
Shares Diluted FY 2025 · Dec 31, 2023 55.51M sh
Capex FY 2025 · Dec 31, 2025 $1.34M
Capex FY 2025 · Dec 31, 2024 $725K
Capex FY 2025 · Dec 31, 2023 $551K
Operating Cash Flow FY 2025 · Dec 31, 2025 $47.33M
Operating Cash Flow FY 2025 · Dec 31, 2024 $171.95M
Operating Cash Flow FY 2025 · Dec 31, 2023 $111.09M
Cash And Equivalents FY 2025 · Dec 31, 2025 $128.45M
Cash And Equivalents FY 2025 · Dec 31, 2024 $69.33M
Cash And Equivalents FY 2025 · Dec 31, 2023 $75.05M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.06B
Stockholders Equity FY 2025 · Dec 31, 2024 $1.04B
Stockholders Equity FY 2025 · Dec 31, 2023 $921.52M
Stockholders Equity FY 2025 · Dec 31, 2022 $886.2M
Current Liabilities FY 2025 · Dec 31, 2025 $338.17M
Current Liabilities FY 2025 · Dec 31, 2024 $292.4M
Total Liabilities FY 2025 · Dec 31, 2025 $390.93M
Total Liabilities FY 2025 · Dec 31, 2024 $332.34M
Current Assets FY 2025 · Dec 31, 2025 $644.18M
Current Assets FY 2025 · Dec 31, 2024 $686.07M
Total Assets FY 2025 · Dec 31, 2025 $1.45B
Total Assets FY 2025 · Dec 31, 2024 $1.37B
Eps Diluted FY 2025 · Dec 31, 2025 −$0.68
Eps Diluted FY 2025 · Dec 31, 2024 $1.32
Eps Diluted FY 2025 · Dec 31, 2023 $0.02
Eps Basic FY 2025 · Dec 31, 2025 −$0.68
Eps Basic FY 2025 · Dec 31, 2024 $1.34
Eps Basic FY 2025 · Dec 31, 2023 $0.02
Sga Expense FY 2025 · Dec 31, 2025 $485.56M
Sga Expense FY 2025 · Dec 31, 2024 $321.58M
Sga Expense FY 2025 · Dec 31, 2023 $336.36M
Rd Expense FY 2025 · Dec 31, 2025 $106.24M
Rd Expense FY 2025 · Dec 31, 2024 $108.8M
Rd Expense FY 2025 · Dec 31, 2023 $91.59M
Net Income FY 2025 · Dec 31, 2025 −$38.55M
Net Income FY 2025 · Dec 31, 2024 $73.87M
Net Income FY 2025 · Dec 31, 2023 $1.32M
Operating Income FY 2025 · Dec 31, 2025 −$62.28M
Operating Income FY 2025 · Dec 31, 2024 $81.67M
Operating Income FY 2025 · Dec 31, 2023 −$5.27M
Cost Of Revenue FY 2025 · Dec 31, 2025 $74.56M
Cost Of Revenue FY 2025 · Dec 31, 2024 $77.91M
Cost Of Revenue FY 2025 · Dec 31, 2023 $83.78M
Revenue FY 2025 · Dec 31, 2025 $718.95M
Revenue FY 2025 · Dec 31, 2024 $661.82M
Revenue FY 2025 · Dec 31, 2023 $607.52M